SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABBY.L Regulatory News (ABBY)

  • There is currently no data for ABBY

Interim Statement

7 Dec 2018 07:00

RNS Number : 7259J
Abbey PLC
07 December 2018
 

ABBEY PLC

 

INTERIM STATEMENT FOR THE SIX MONTHS ENDED 31 OCTOBER 2018

 

 

The Board of Abbey plc reports a profit before taxation of €23.93m which compares with a profit of €23.42m for the corresponding period last year. Profits at the operating level were €23.93m as compared to €23.42m at the half way stage last year.

 

Our housebuilding division completed 277 sales (UK 239; Ireland 19; Czechia 19) with a turnover of €99.17m resulting in an operating profit of €21.52m. Trading in the UK has held up well over the six months. Margins, as previously guided, have reduced in line with our expectations. Forward sales continue to be encouraging. In particular our projects aimed directly at first time buyers are selling well. Production continues to be impacted by tight labour and materials markets and some delays have been experienced. Costs are rising. As always trading in the last quarter will determine our final result. In Ireland production will soon be in progress on five projects and we are hoping for a useful contribution to our year end figures. A further four projects are making their way through the approvals process as efforts continue to grow our Irish business. In Prague good sales were achieved at our Prezlitice project. Work has commenced on the new project for 154 apartments in Horomerice.

 

M & J Engineers, our UK plant hire business, generated operating profits of €1.88m on a turnover of €10.98m. A fair outcome is in prospect for the year, however trading over recent weeks, whilst ahead of last year, has been slightly behind our target.

 

Rental income for the period amounted to €534,000.

 

The Group maintained good cash flow during the period and held €93.38m in cash at the end of October.

 

The Board has carefully reviewed the current financial position of the Group together with likely future commitments. As a result the Board is pleased to declare a special dividend of 100.00 cents per share payable on the 31st January 2019 to shareholders on the register at 4th January 2019.

 

In addition the Board is declaring a dividend of 9.00 cents per share to be paid on 30th April 2019 to shareholders on the register at 5th April 2019. Together with the 10.00 cents per share approved at the AGM in October this will make a total of 119.00 cents per share for the financial year.

 

Shareholders should carefully note the exchange rates used for this statement. The income statement uses the average rate for the period of 100 cents: STG88.60 and 100 cents: CZK 25.74. The balance sheet uses the rate prevailing on 31 October 2018 of 100 cents: STG 88.68 and 100 cents: CZK 25.94.

 

Whilst our UK forward sales position gives confidence that a reasonable result for the year will be achieved the continuing uncertain external conditions are cause for concern. The Group will continue to progress all its activities but intends to be cautious about new investments in the months ahead.

 

Copies of this statement are available to shareholders and members of the public at the company's registered office, 25\28 North Wall Quay, Dublin 1.

 

On behalf of the Board

Charles H Gallagher - Chairman

7th December 2018

 

The Interim Results for the six months ended to 31 October 2018 can be accessed by clicking on the following link:

 

http://www.rns-pdf.londonstockexchange.com/rns/7259J_1-2018-12-6.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR KMMGZKVRGRZM
Date   Source Headline
10th Jul 20127:00 amRNSPreliminary Statement
4th May 20127:00 amRNSShare Buy Back
3rd May 20127:00 amRNSShare Buy Back
17th Feb 20128:55 amRNSHolding in Company
17th Feb 20127:00 amRNSShare Buyback
9th Feb 20127:00 amRNSShare Buy Back
31st Jan 20127:00 amRNSShare Buy Back
27th Jan 20127:00 amRNSShare Buy Back
25th Jan 20127:00 amRNSShare Buy Back
5th Jan 20127:00 amRNSShare Buy Back
23rd Dec 20111:34 pmRNSShare Buy Back
14th Dec 20117:00 amRNSShare Buy Back
9th Dec 20117:00 amRNSShare Buy Back
8th Dec 20117:00 amRNSInterim Results
7th Dec 20114:18 pmRNSBoard Appointment
24th Oct 20117:00 amRNSShare Buy Back
19th Oct 20117:00 amRNSShare Buy Back
18th Oct 20118:41 amRNSHolding in Company
18th Oct 20117:00 amRNSShare Buy Back
17th Oct 20117:00 amRNSShare Buy Back
7th Oct 201111:59 amRNSRetirement of Director and AGM Results
7th Oct 201110:30 amRNSAGM Statement
5th Oct 20115:21 pmRNSAnnual Report and Accounts
20th Sep 20117:00 amRNSShare Buy Back
7th Sep 20117:00 amRNSShare Buy Back
6th Sep 20117:00 amRNSShare Buy Back
5th Sep 20117:00 amRNSShare Buy Back
1st Sep 20117:00 amRNSShare Buyback
22nd Aug 20119:38 amRNSHolding in Company
22nd Aug 20117:00 amRNSShare Buy Back
19th Aug 20111:35 pmRNSHolding(s) in Company
18th Aug 20116:02 pmRNSShare Buy Back
18th Aug 20117:00 amRNSShare BuyBack
11th Aug 20117:00 amRNSShare Buy Back
5th Aug 20117:00 amRNSShare Buy Back
4th Aug 20117:00 amRNSShare Buy Back
21st Jul 20117:00 amRNSShare Buy Back
18th Jul 20117:00 amRNSShare Buy Back
14th Jul 20117:00 amRNSPreliminary Statement
26th May 20114:33 pmRNSHolding(s) in Company
24th May 20119:07 amRNSHolding(s) in Company
3rd May 20119:00 amRNSHolding(s) in Company
28th Apr 20114:42 pmRNSShare Buy Back
4th Apr 20117:00 amRNSShare Buy Back
16th Mar 20117:00 amRNSShare Buy Back
2nd Mar 20114:34 pmRNSHolding(s) in Company
1st Mar 20117:00 amRNSShare Buy Back
17th Feb 20117:00 amRNSShare Buy Back
4th Feb 20117:00 amRNSShare Buy Back
25th Jan 20119:51 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.